Incorporation of functionalized carbon nanotubes into hydrophobic drug crystals for enhancing aqueous dissolution.


Journal

Colloids and surfaces. B, Biointerfaces
ISSN: 1873-4367
Titre abrégé: Colloids Surf B Biointerfaces
Pays: Netherlands
ID NLM: 9315133

Informations de publication

Date de publication:
01 Jan 2019
Historique:
received: 06 06 2018
revised: 28 09 2018
accepted: 29 09 2018
pubmed: 15 10 2018
medline: 26 3 2019
entrez: 15 10 2018
Statut: ppublish

Résumé

We present for the first time the direct incorporation of carboxylated carbon nanotubes (f-CNTs) into hydrophobic drug particles during their formation via anti-solvent precipitation. The approach was tested using two drugs namely antifungal agent Griseofulvin (GF) and antibiotic Sulfamethoxazole (SMZ) that had very different aqueous solubility. It was observed that the f-CNTs dispersed in the water served as nucleating sites for crystallization and were readily incorporated into the drug particles without altering crystal structure or other properties. The results showed that the hydrophilic f-CNTs dramatically enhanced dissolution rate for both drugs, and the time necessary to reach 80% dissolution (t

Identifiants

pubmed: 30317125
pii: S0927-7765(18)30694-5
doi: 10.1016/j.colsurfb.2018.09.080
pmc: PMC6292730
mid: NIHMS1509504
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antifungal Agents 0
Nanotubes, Carbon 0
Solvents 0
Water 059QF0KO0R
Griseofulvin 32HRV3E3D5
Sulfamethoxazole JE42381TNV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

386-391

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES023209
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Références

Nano Lett. 2011 Jul 13;11(7):2796-803
pubmed: 21657258
Environ Health Perspect. 2008 Sep;116(9):1211-7
pubmed: 18795165
Angew Chem Int Ed Engl. 2005 Oct 7;44(39):6358-62
pubmed: 16138384
Nat Nanotechnol. 2008 Jul;3(7):423-8
pubmed: 18654567
J Biomed Opt. 2009 Mar-Apr;14(2):021009
pubmed: 19405722
Small. 2009 May;5(10):1176-85
pubmed: 19306454
Chem Commun (Camb). 2012 Apr 25;48(33):3911-26
pubmed: 22428156
J Am Chem Soc. 2003 May 21;125(20):6160-4
pubmed: 12785847
Mater Sci Eng C Mater Biol Appl. 2018 Aug 1;89:274-282
pubmed: 29752099
Biotechnol Appl Biochem. 2015 Sep-Oct;62(5):598-605
pubmed: 25347997
Chem Commun (Camb). 2009 Aug 7;(29):4447-9
pubmed: 19597621
Colloids Surf B Biointerfaces. 2008 Jul 15;64(2):194-9
pubmed: 18325744
Mol Biosyst. 2005 Jul;1(2):176-82
pubmed: 16880981
Int J Pharm. 2004 Oct 13;284(1-2):109-22
pubmed: 15454302
Biomaterials. 2012 Apr;33(11):3334-43
pubmed: 22289266
Adv Drug Deliv Rev. 2011 May 30;63(6):406-16
pubmed: 21457742
Environ Sci Technol. 2005 Mar 1;39(5):1378-83
pubmed: 15787380
ACS Nano. 2010 Dec 28;4(12):7717-25
pubmed: 21117641
Biochim Biophys Acta. 2006 Mar;1758(3):404-12
pubmed: 16307724
Nat Nanotechnol. 2011 Feb;6(2):121-125
pubmed: 21278749
Int J Pharm. 2006 Jul 6;317(1):61-8
pubmed: 16647232
Biomaterials. 2007 Oct;28(28):4078-90
pubmed: 17576009
ACS Nano. 2011 Jan 25;5(1):199-208
pubmed: 21141979
Nano Lett. 2006 Dec;6(12):2642-5
pubmed: 17163681
Chem Biol. 2003 Oct;10(10):961-6
pubmed: 14583262
J Am Chem Soc. 2007 Jul 11;129(27):8438-9
pubmed: 17569542
Biomaterials. 2012 Jun;33(19):4818-27
pubmed: 22483242
ACS Nano. 2009 Nov 24;3(11):3707-13
pubmed: 19877694
Nat Nanotechnol. 2010 May;5(5):354-9
pubmed: 20364135
Toxicol Rep. 2016 Jan 19;3:230-243
pubmed: 28959543
J Pharm Sci. 1981 Jul;70(7):789-93
pubmed: 7264929
Chem Commun (Camb). 2008 Jan 28;(4):459-61
pubmed: 18188467
ACS Nano. 2007 Aug;1(1):50-6
pubmed: 19203129
Chem Commun (Camb). 2006 Mar 21;(11):1182-4
pubmed: 16518484
Small. 2011 Oct 4;7(19):2727-35
pubmed: 21861293
Carbon N Y. 2019 May 2;50(4):1625-1634
pubmed: 31105316
Biomaterials. 2007 Jan;28(2):344-53
pubmed: 16934866
J Nucl Med. 2007 Jul;48(7):1180-9
pubmed: 17607040
Bone. 2008 Aug;43(2):362-370
pubmed: 18541467
Nat Nanotechnol. 2008 Jul;3(7):434-9
pubmed: 18654569
J Nanopart Res. 2017 Jan;19:
pubmed: 29046611
Int J Pharm. 2017 Sep 15;530(1-2):263-278
pubmed: 28774853
Nano Lett. 2012 Apr 11;12(4):1831-8
pubmed: 22432413
Colloids Surf B Biointerfaces. 2017 Aug 1;156:123-132
pubmed: 28527356
Small. 2012 May 21;8(10):1543-50
pubmed: 22422554
Toxicol Lett. 2007 Jan 10;168(1):58-74
pubmed: 17141434
Cancer Res. 2008 Aug 15;68(16):6652-60
pubmed: 18701489
Int J Pharm. 2013 May 1;448(1):115-22
pubmed: 23524119

Auteurs

Kun Chen (K)

Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, 07102, USA.

Somenath Mitra (S)

Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, 07102, USA. Electronic address: Somenath.Mitra@njit.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH